Antibody against CD20 in patients with B cell malignancy
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology,Hematology
Reference25 articles.
1. Phase II trial of 131I-B1 (anti-CD20) antibody therapy with autologous stem cell transplantation for relapsed B cell lymphomas;Press;Lancet,1995
2. Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20;Reff;Blood,1994
3. Use of rituximab, the new FDA-approved antibody;Leget;Curr. Opin. Oncol.,1998
4. Mouse/human chimeric monoclonal antibody in man: kinetics and immune response;LoBuglio;Proc. Natl. Acad. Sci. USA,1989
5. Human antibodies with sub-nanomolar affinities isolated from a large non-immunized phage display library [see comments];Vaughan;Nat. Biotechnol.,1996
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Anticancer Activities of Anti-Membrane Antibodies against Colon Carcinoma Cells Undergoing Chemotherapy;Tumori Journal;2013-01
2. A common repertoire of autoantibodies is shared by cancer and autoimmune disease patients: Inflammation in their induction and impact on tumor growth;Cancer Letters;2009-08
3. Development of autoimmunity in lymphoma;Expert Review of Clinical Immunology;2008-03
4. Evaluation of a peptide ELISA for the detection of rituximab in serum;Journal of Immunological Methods;2007-08
5. Improved antigen binding by a CD20-specific single-chain antibody fragment with a mutation in CDRH1;Molecular Immunology;2006-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3